查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514894

IPV 疫苗市場，按疫苗類型、年齡層、分佈、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

IPV Vaccines Market, By Vaccine Type, By Age Group, By Distribution, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 379 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年IPV疫苗市場規模為1.8945億美元，2024年至2032年複合年成長率為8.3%。

IPV疫苗市場-市場動態

政府對免疫計劃的資助增加推動了 IPV 疫苗的採用

多項措施證明，政府對免疫計畫的資助增加顯著促進了 IPV 疫苗的採用。例如，世界衛生組織 (WHO) 報告稱，2020 年，由於加強了疫苗接種工作，全球脊髓灰質炎病例減少了 90%。此外，美國政府還撥款 2.37 億美元用於 2021 年根除小兒麻痺工作，進一步強調了廣泛分發 IPV 疫苗的承諾。這些大量投資對於確保 IPV 疫苗的可用性和可近性至關重要，最終推動更高的免疫率並使全球根除小兒麻痺的目標更接近現實。

IPV 疫苗市場 - 主要見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 8.3% 左右的複合年成長率成長

根據疫苗類型細分，預計 IPV 疫苗將在 2023 年佔據最大市場佔有率

依年齡層細分，2023年兒科為主導類型

按分佈細分，公共疫苗接種計畫是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

IPV 疫苗市場 - 細分分析：

全球 IPV 疫苗市場根據疫苗類型、年齡層、分佈、最終用戶和地區進行細分。

市場依疫苗類型分為兩類：去活化小兒麻痺病毒疫苗和口服小兒麻痺病毒疫苗。與口服小兒麻痺病毒疫苗相比，去活化小兒麻痺病毒疫苗的安全性更高，加上政府的大力支持和旨在透過IPV 免疫計畫根除小兒麻痺的國際努力，推動了去活化小兒麻痺質炎病毒疫苗領域的市場領先。

市場依年齡層分為兩類：兒科和成人。兒科領域佔有最高佔有率，這是由針對兒童的全球免疫計劃推動的，該計劃是按照醫療保健指南的規定，並得到廣泛的政府和國際計劃的支持，以兒童為對象從小預防脊髓灰質炎。

IPV 疫苗市場 - 地理洞察

在北美，強而有力的政府支持和健全的醫療保健系統確保了 IPV 疫苗的高採用率。在全面免疫計畫和歐洲疫苗行動計畫等措施的推動下，歐洲也展現了重要的市場影響力。亞太地區，特別是印度和中國，由於人口眾多以及各國政府以及世界衛生組織和聯合國兒童基金會等國際組織支持的積極根除小兒麻痺運動，代表了一個迅速擴大的部分。非洲小兒麻痺發生率最高，儘管由於基礎設施限制仍然存在挑戰，但全球衛生組織在 IPV 疫苗分發方面做出了大量努力。在區域免疫活動和改善醫療服務的推動下，拉丁美洲市場呈現穩定成長。

IPV 疫苗市場-競爭格局：

IPV疫苗市場的特點是領先製藥公司之間競爭激烈，每家公司都努力透過創新、策略聯盟和廣泛的分銷網路來提高自己的市場佔有率。賽諾菲巴斯德、葛蘭素史克和輝瑞等主要參與者佔據市場主導地位，利用其廣泛的研發能力和全球影響力推出有效和安全的 IPV 疫苗。這些公司經常與政府機構和世界衛生組織和聯合國兒童基金會等全球衛生組織建立夥伴關係，以支持大規模免疫計畫。在需求成長和政府支持政策的推動下，新興企業和區域製造商也正在進入市場。此外，疫苗技術的進步，例如改進的儲存解決方案和聯合疫苗，正在加劇競爭，因為公司尋求差異化其產品並擴大其在已開發和發展中地區的業務。

最近的發展：

2023 年 12 月，Panacea Biotec 在印度推出了 EasyFourPol，這是一種全液體五價疫苗，可保護兒童免受白喉、破傷風、百日咳、小兒麻痺和 B 型流感嗜血桿菌感染。

2024 年 4 月，《商業標準》宣布印度有能力在 3-4 個月內供應全部 IPV，強調需要額外劑量以維持該國的無脊髓灰質炎狀態。賽諾菲和印度血清研究所 (SII) 被確定為主要 IPV 疫苗供應商，其中賽諾菲貢獻了約 80% 的需求。

目錄

第 1 章：IPV 疫苗市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • IPV 疫苗市場片段（依疫苗類型）
    • 按年齡層別分類的 IPV 疫苗市場片段
    • 按分佈分類的 IPV 疫苗市場片段
    • 最終用戶的 IPV 疫苗市場摘要
    • 按國家/地區分類的 IPV 疫苗市場摘要
    • 按地區分類的 IPV 疫苗市場片段
  • 競爭洞察

第 3 章：IPV 疫苗主要市場趨勢

  • IPV 疫苗市場促進因素
    • 市場促進因素的影響分析
  • IPV 疫苗市場限制
    • 市場限制影響分析
  • IPV疫苗市場機會
  • IPV疫苗市場未來趨勢

第 4 章：IPV 疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：IPV 疫苗市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：IPV 疫苗市場格局

  • 2023 年 IPV 疫苗市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：IPV 疫苗市場 - 依疫苗類型

  • 概述
    • 按疫苗類型分類的細分市場佔有率分析
    • 去活化小兒麻痺病毒疫苗 (IPV)
    • 口服小兒麻痺病毒疫苗 (OPV)

第 8 章：IPV 疫苗市場 - 按年齡層

  • 概述
    • 按年齡層別分類的細分市場佔有率分析
    • 兒科
    • 成年人

第 9 章：IPV 疫苗市場 - 按分佈

  • 概述
    • 按分佈分類的細分市場佔有率分析
    • 公共疫苗接種計劃
    • 私人疫苗接種診所
    • 藥局
    • 網路藥局

第 10 章：IPV 疫苗市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 公共衛生機構
    • 其他

第 11 章：IPV 疫苗市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • IPV 疫苗北美主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按疫苗類型）
    • 北美市場規模和預測（按年齡層）
    • 北美市場規模和預測（按分佈）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲 IPV 疫苗主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按疫苗類型）
    • 歐洲市場規模和預測（按年齡層）
    • 歐洲市場規模和預測（按分佈）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區 IPV 疫苗主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依疫苗類型）
    • 亞太地區市場規模與預測（依年齡層）
    • 亞太地區市場規模與預測（按分佈）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲 IPV 疫苗主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按疫苗類型）
    • 拉丁美洲市場規模與預測（按年齡層）
    • 拉丁美洲市場規模與預測（按分佈）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲 IPV 疫苗主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按疫苗類型）
    • 中東和非洲市場規模及預測（按年齡層）
    • 中東和非洲市場規模及預測（按分佈）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - IPV 疫苗產業

  • 競爭儀表板
  • 公司簡介
    • Sanofi Pasteur
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Johnson & Johnson
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Panacea Biotec Ltd.
    • Bio Farma
    • Sinovac Biotech Ltd.
    • Astellas Pharma Inc.
    • Sinopharm Group Co., Ltd.
    • Valneva SE
    • Innovax
    • LG Chem
    • PT Bio Farma (Persero)
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3035

REPORT HIGHLIGHT

IPV Vaccines Market size was valued at USD 189.45 million in 2023, expanding at a CAGR of 8.3% from 2024 to 2032.

The IPV Vaccines Market, defined as the sector dedicated to inactivated poliovirus vaccines used for polio prevention, is experiencing growth driven by global immunization initiatives and increasing awareness of polio eradication. The robust government vaccination programs, support from organizations like WHO and UNICEF, and rising incidences of polio in certain regions are propelling the market demand. However, market growth is restrained by the high costs of vaccine development and distribution challenges in remote areas. Nonetheless, opportunities exist in the development of combination vaccines, advancements in vaccine storage and delivery technologies, and increasing investments in healthcare infrastructure in emerging economies.

IPV Vaccines Market- Market Dynamics

Increased Government Funding for Immunization Programs Fuels Adoption of IPV Vaccines

Increased government funding for immunization programs is significantly boosting the adoption of IPV vaccines, as evidenced by initiatives. For instance, in 2020, the World Health Organization (WHO) reported a 90% reduction in polio cases worldwide due to enhanced vaccination efforts. Additionally, the U.S. government allocated USD 237 million to polio eradication efforts in 2021, further emphasizing the commitment to widespread IPV vaccine distribution. These substantial investments are crucial in ensuring the availability and accessibility of IPV vaccines, ultimately driving higher immunization rates and bringing the goal of global polio eradication closer to reality.

IPV Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.3% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, IPV vaccines were predicted to show maximum market share in the year 2023

Based on Age Group segmentation, Pediatrics was the leading type in 2023

Based on distribution segmentation, Public Vaccination Programs were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

IPV Vaccines Market- Segmentation Analysis:

The Global IPV vaccine market is segmented based on Vaccine Type, Age Group, Distribution, End-User, and Region.

The market is divided into two categories based on Vaccine Type: Inactivated Poliovirus Vaccine, and Oral Poliovirus Vaccine. The Inactivated Poliovirus Vaccine segment led the market, driven by its enhanced safety profile compared to the Oral Poliovirus Vaccine, alongside strong government support and international efforts aimed at polio eradication through IPV immunization programs.

The market is divided into two categories based on Age Group: Pediatrics, and Adults. The pediatrics segment holds the highest share, driven by global immunization programs targeting children to prevent polio from an early age, as mandated by healthcare guidelines and supported by extensive government and international initiatives.

IPV Vaccines Market- Geographical Insights

In North America, strong government support and robust healthcare systems ensure high adoption rates of IPV vaccines. Europe also demonstrates a significant market presence, driven by comprehensive immunization programs and initiatives like the European Vaccine Action Plan. Asia-Pacific, particularly India and China, represents a rapidly expanding segment due to large populations and aggressive polio eradication campaigns supported by both governments and international organizations like WHO and UNICEF. Africa, facing the highest polio prevalence, sees substantial efforts in IPV vaccine distribution funded by global health organizations, although challenges remain due to infrastructural limitations. Latin America shows steady market growth fueled by regional immunization drives and improving healthcare access.

IPV Vaccines Market- Competitive Landscape:

The IPV vaccine market is characterized by strong competition among leading pharmaceutical companies, each striving to enhance their market share through innovation, strategic alliances, and extensive distribution networks. Major players such as Sanofi Pasteur, GlaxoSmithKline, and Pfizer dominate the market, leveraging their extensive R&D capabilities and global reach to introduce effective and safe IPV vaccines. These companies frequently engage in partnerships with government bodies and global health organizations like WHO and UNICEF to support large-scale immunization programs. Emerging players and regional manufacturers are also entering the market, driven by increasing demand and supportive governmental policies. Additionally, advancements in vaccine technology, such as improved storage solutions and combination vaccines, are intensifying competition as companies seek to differentiate their offerings and expand their presence in both developed and developing regions.

Recent Developments:

In December 2023, Panacea Biotec launched EasyFourPol, a fully liquid pentavalent vaccine in India, safeguarding children against diphtheria, tetanus, pertussis, polio, and Haemophilus influenza type B infections.

In April 2024, The Business Standard announced India's capability to supply its entire IPV within 3-4 months, emphasizing the necessity of additional doses to sustain the nation's polio-free status. Sanofi and Serum Institute of India (SII) are identified as the primary IPV vaccine suppliers, with Sanofi contributing approximately 80% of the requirement.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IPV VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Sanofi Pasteur

GlaxoSmithKline plc

Pfizer Inc.

Merck & Co., Inc.

Johnson & Johnson

Serum Institute of India Pvt. Ltd.

Bharat Biotech

Panacea Biotec Ltd.

Bio Farma

Sinovac Biotech Ltd.

Astellas Pharma Inc.

Sinopharm Group Co., Ltd.

Valneva SE

Innovax

LG Chem

PT Bio Farma (Persero)

Others

GLOBAL IPV VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Inactivated Poliovirus Vaccine (IPV)
  • Oral Poliovirus Vaccine (OPV)

GLOBAL IPV VACCINES MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019 - 2032

  • Pediatrics
  • Adults

GLOBAL IPV VACCINES MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Public Vaccination Programs
  • Private Vaccination Clinics
  • Pharmacies
  • Online Pharmacies

GLOBAL IPV VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Public Health Agencies
  • Others

GLOBAL IPV VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. IPV Vaccines Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. IPV Vaccines Market Snippet by Vaccine Type
    • 2.1.2. IPV Vaccines Market Snippet by Age Group
    • 2.1.3. IPV Vaccines Market Snippet by Distribution
    • 2.1.4. IPV Vaccines Market Snippet by End-User
    • 2.1.5. IPV Vaccines Market Snippet by Country
    • 2.1.6. IPV Vaccines Market Snippet by Region
  • 2.2. Competitive Insights

3. IPV Vaccines Key Market Trends

  • 3.1. IPV Vaccines Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. IPV Vaccines Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. IPV Vaccines Market Opportunities
  • 3.4. IPV Vaccines Market Future Trends

4. IPV Vaccines Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. IPV Vaccines Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. IPV Vaccines Market Landscape

  • 6.1. IPV Vaccines Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. IPV Vaccines Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
    • 7.1.2. Inactivated Poliovirus Vaccine (IPV)
    • 7.1.3. Oral Poliovirus Vaccine (OPV)

8. IPV Vaccines Market - By Age Group

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Age Group, 2023 & 2032 (%)
    • 8.1.2. Pediatrics
    • 8.1.3. Adults

9. IPV Vaccines Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Public Vaccination Programs
    • 9.1.3. Private Vaccination Clinics
    • 9.1.4. Pharmacies
    • 9.1.5. Online Pharmacies

10. IPV Vaccines Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Public Health Agencies
    • 10.1.5. Others

11. IPV Vaccines Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. IPV Vaccines Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. IPV Vaccines Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. IPV Vaccines Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. IPV Vaccines Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. IPV Vaccines Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- IPV Vaccines Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Sanofi Pasteur
    • 12.2.2. GlaxoSmithKline plc
    • 12.2.3. Pfizer Inc.
    • 12.2.4. Merck & Co., Inc.
    • 12.2.5. Johnson & Johnson
    • 12.2.6. Serum Institute of India Pvt. Ltd.
    • 12.2.7. Bharat Biotech
    • 12.2.8. Panacea Biotec Ltd.
    • 12.2.9. Bio Farma
    • 12.2.10. Sinovac Biotech Ltd.
    • 12.2.11. Astellas Pharma Inc.
    • 12.2.12. Sinopharm Group Co., Ltd.
    • 12.2.13. Valneva SE
    • 12.2.14. Innovax
    • 12.2.15. LG Chem
    • 12.2.16. PT Bio Farma (Persero)
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE IPV Vaccines Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global IPV Vaccines Market, by Vaccine Type 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: Age Group Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Age Group
  • TABLE Global IPV Vaccines Market, by Age Group 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: Distribution Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global IPV Vaccines Market, by Distribution 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global IPV Vaccines Market, by End-User 2019-2032 (USD Million)
  • TABLE IPV Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global IPV Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE North America IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Europe IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Asia Pacific IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Latin America IPV Vaccines Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Vaccine Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by Distribution, 2019-2032 (USD Million)
  • TABLE Middle East and Africa IPV Vaccines Market, by End-User, 2019-2032 (USD Million)

List of Figures

  • FIGURE IPV Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Vaccine Type segment market share analysis, 2023 & 2032
  • FIGURE Vaccine Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Age Group segment market share analysis, 2023 & 2032
  • FIGURE Age Group segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Distribution segment market share analysis, 2023 & 2032
  • FIGURE Distribution segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End-User segment market share analysis, 2023 & 2032
  • FIGURE End-User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America IPV Vaccines Market share and leading players, 2023
  • FIGURE Europe IPV Vaccines Market share and leading players, 2023
  • FIGURE Asia Pacific IPV Vaccines Market share and leading players, 2023
  • FIGURE Latin America IPV Vaccines Market share and leading players, 2023
  • FIGURE Middle East and Africa IPV Vaccines Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe IPV Vaccines Market share analysis by country, 2023
  • FIGURE Germany IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific IPV Vaccines Market share analysis by country, 2023
  • FIGURE India IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America IPV Vaccines Market share analysis by country, 2023
  • FIGURE Brazil IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa IPV Vaccines Market share analysis by country, 2023
  • FIGURE Saudi Arabia IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA IPV Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)